(Total Views: 400)
Posted On: 01/07/2020 10:45:44 AM
Post# of 219

$SYN News Article - Synthetic Biologics Receives FDA Guidance at Type C Meeting for SYN-004 (ribaxamase) Phase 1b/2a Clinical Trial in Allogeneic HCT Recipients https://marketwirenews.com/news-releases/synt...11256.html


My Twitter: WhyteStocks